NO975662D0 - Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer - Google Patents

Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer

Info

Publication number
NO975662D0
NO975662D0 NO975662A NO975662A NO975662D0 NO 975662 D0 NO975662 D0 NO 975662D0 NO 975662 A NO975662 A NO 975662A NO 975662 A NO975662 A NO 975662A NO 975662 D0 NO975662 D0 NO 975662D0
Authority
NO
Norway
Prior art keywords
cancer
drug
preparation
treatment
triazole derivatives
Prior art date
Application number
NO975662A
Other languages
English (en)
Other versions
NO975662L (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO975662D0 publication Critical patent/NO975662D0/no
Publication of NO975662L publication Critical patent/NO975662L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO975662A 1995-06-07 1997-12-05 Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer NO975662L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/473,819 US5770616A (en) 1995-06-07 1995-06-07 Pharmaceutical composition for inhibiting the growth of cancers
PCT/US1996/007444 WO1996040119A1 (en) 1995-06-07 1996-05-22 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers

Publications (2)

Publication Number Publication Date
NO975662D0 true NO975662D0 (no) 1997-12-05
NO975662L NO975662L (no) 1998-02-09

Family

ID=23881121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975662A NO975662L (no) 1995-06-07 1997-12-05 Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer

Country Status (20)

Country Link
US (4) US5770616A (no)
EP (1) EP0831814A1 (no)
JP (1) JPH11508233A (no)
KR (1) KR19990022619A (no)
CN (1) CN1190344A (no)
AR (1) AR003138A1 (no)
AU (1) AU707077B2 (no)
BR (1) BR9608731A (no)
CA (1) CA2223967A1 (no)
CZ (1) CZ391797A3 (no)
HU (1) HUP9802677A3 (no)
IL (1) IL118425A (no)
NO (1) NO975662L (no)
NZ (1) NZ308391A (no)
PL (1) PL324107A1 (no)
RU (1) RU2177316C2 (no)
SK (1) SK168597A3 (no)
TR (2) TR199701534T1 (no)
WO (1) WO1996040119A1 (no)
ZA (1) ZA964374B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6200992B1 (en) * 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5908855A (en) * 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
CN100334084C (zh) * 2005-04-26 2007-08-29 武汉大学 联三唑化合物及其制备方法和用途
US20070116643A1 (en) * 2005-07-01 2007-05-24 Concert Pharmaceuticals Inc. Novel aryloxypropanamines
AU2006318476A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) * 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) * 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4490540A (en) * 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
DE3238903A1 (de) * 1982-10-21 1984-04-26 Bayer Ag, 5090 Leverkusen Antivirales mittel
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
DE3511409A1 (de) * 1985-03-29 1986-10-02 Basf Ag, 6700 Ludwigshafen Herstellung von arzneimitteln gegen viruserkrankungen
DE3511411A1 (de) * 1985-03-29 1986-10-02 Basf Ag, 6700 Ludwigshafen Verwendung von azolylmethyloxiranen zur bekaempfung von viralen erkrankungen
US5211736A (en) * 1988-05-09 1993-05-18 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH02257929A (ja) * 1989-03-09 1990-10-18 Makutaa Kk 生体透過率測定器
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
RO114129B1 (ro) 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
ZA962880B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en) 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
AU714056B2 (en) 1995-04-12 1999-12-16 Uaf Technologies And Research Llc A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US5629341A (en) 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en) 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections
MX9707809A (es) 1995-06-07 1998-01-31 Procter & Gamble Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
KR19990022617A (ko) 1995-06-07 1999-03-25 데이비드 엠 모이어 백혈병 치료용 약제의 제조를 위한 벤즈이미다졸의 용도
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6200992B1 (en) 1995-06-07 2001-03-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
PL324905A1 (en) 1995-08-03 1998-06-22 Procter & Gamble Application of griseofulvin in carcinoma development inhibition
US5908855A (en) 1996-07-16 1999-06-01 The Procter & Gamble Company Compositions for treating viral infections
IL123095A0 (en) 1995-08-04 1998-09-24 Procter & Gamble Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment

Also Published As

Publication number Publication date
IL118425A0 (en) 1996-09-12
IL118425A (en) 2001-05-20
HUP9802677A2 (hu) 1999-08-30
CZ391797A3 (cs) 1998-05-13
JPH11508233A (ja) 1999-07-21
AU5801996A (en) 1996-12-30
NO975662L (no) 1998-02-09
BR9608731A (pt) 1999-06-29
AR003138A1 (es) 1998-07-08
CA2223967A1 (en) 1996-12-19
AU707077B2 (en) 1999-07-01
HUP9802677A3 (en) 1999-11-29
US5770616A (en) 1998-06-23
CN1190344A (zh) 1998-08-12
TR199701534T1 (xx) 1998-02-21
NZ308391A (en) 2000-05-26
SK168597A3 (en) 1998-12-02
TR199801323T2 (xx) 1998-09-21
RU2177316C2 (ru) 2001-12-27
WO1996040119A1 (en) 1996-12-19
US5872142A (en) 1999-02-16
US6025377A (en) 2000-02-15
PL324107A1 (en) 1998-05-11
KR19990022619A (ko) 1999-03-25
ZA964374B (en) 1997-02-17
US6228876B1 (en) 2001-05-08
EP0831814A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
NO975661D0 (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
NO975662D0 (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
HUT71582A (en) Potentiation of drug response
AU4048295A (en) Peptide medicaments for the treatment of disease
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO910395D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
GB9508823D0 (en) Drug Derivatives
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
FI964229A0 (fi) Menetelmä doksorubisiinin valmistamiseksi
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
FI973644A (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
EP0790062A4 (en) REMEDY FOR HEART DISEASE
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
NO913162L (no) Farmasoeytisk preparat for behandling av tonsillitt.
EE9600021A (et) Asendatud indoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
GB9524942D0 (en) Drug therapy
NZ323421A (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
AU1014997A (en) A drug for the treatment of cancer
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
RU95122486A (ru) Средство для лечения тикозных гиперкинезов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application